Application Sponsors
ANDA 213306 | GRANULES PHARMS | |
Marketing Status
Application Products
001 | FOR SOLUTION;ORAL | 50MG/ML | 0 | VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2020-01-31 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2022-06-29 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
GRANULES PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 213306
[companyName] => GRANULES PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"VALGANCICLOVIR HYDROCHLORIDE","activeIngredients":"VALGANCICLOVIR HYDROCHLORIDE","strength":"50MG\/ML","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"01\/31\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2020-01-31
)
)